Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 176

1.

Rocuronium antagonized by sugammadex for series of electroconvulsive therapy (ECT) in a patient with pseudocholinesterase deficiency.

Batistaki C, Kesidis K, Apostolaki S, Kostopanagiotou G.

J ECT. 2011 Mar;27(1):e47-8. doi: 10.1097/YCT.0b013e318205e1d3.

PMID:
21206368
[PubMed - indexed for MEDLINE]
2.

Rocuronium-sugammadex decreases the severity of post-electroconvulsive therapy agitation.

Postaci A, Tiryaki C, Sacan O, Ornek D, Kalyoncu M, Dikmen B.

J ECT. 2013 Mar;29(1):e2-3. doi: 10.1097/YCT.0b013e31825de0de.

PMID:
23422529
[PubMed - indexed for MEDLINE]
3.

Rocuronium and sugammadex used effectively for electroconvulsive therapy in a patient with Brugada syndrome.

Konishi J, Suzuki T, Kondo Y, Baba M, Ogawa S.

J ECT. 2012 Jun;28(2):e21-2. doi: 10.1097/YCT.0b013e31824b74f5.

PMID:
22622300
[PubMed - indexed for MEDLINE]
4.

[Effective reversal of muscle relaxation by rocuronium using sugammadex in a patient with myasthenia gravis undergoing laparoscopic cholecystectomy].

Komasawa N, Noma H, Sugi T, Sukenaga N, Kakiuchi H.

Masui. 2011 Apr;60(4):476-9. Japanese.

PMID:
21520600
[PubMed - indexed for MEDLINE]
5.

A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia.

Duvaldestin P, Kuizenga K, Saldien V, Claudius C, Servin F, Klein J, Debaene B, Heeringa M.

Anesth Analg. 2010 Jan 1;110(1):74-82. doi: 10.1213/ANE.0b013e3181c3be3c. Epub 2009 Nov 21.

PMID:
19933538
[PubMed - indexed for MEDLINE]
6.

Rocuronium reversed by sugammadex for electroconvulsive therapy in a patient with prolonged duration of action of succinylcholine.

Visser WA, Ermens AA, De Boer HD, Van Os E.

Anaesth Intensive Care. 2011 Nov;39(6):1153-4. No abstract available.

PMID:
22165379
[PubMed - indexed for MEDLINE]
7.

Comparison of recovery times from rocuronium-induced muscle relaxation after reversal with three different doses of sugammadex and succinylcholine during electroconvulsive therapy.

Kadoi Y, Hoshi H, Nishida A, Saito S.

J Anesth. 2011 Dec;25(6):855-9. doi: 10.1007/s00540-011-1236-y. Epub 2011 Sep 24.

PMID:
21947754
[PubMed - indexed for MEDLINE]
8.

Cochrane corner: sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.

Abrishami A, Ho J, Wong J, Yin L, Chung F.

Anesth Analg. 2010 Apr 1;110(4):1239. doi: 10.1213/ANE.0b013e3181ce8d5e.

PMID:
20357160
[PubMed - indexed for MEDLINE]
9.

Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study.

Sorgenfrei IF, Norrild K, Larsen PB, Stensballe J, Ostergaard D, Prins ME, Viby-Mogensen J.

Anesthesiology. 2006 Apr;104(4):667-74.

PMID:
16571960
[PubMed - indexed for MEDLINE]
Free Article
10.

Sugammadex: a review of its use in anaesthetic practice.

Yang LP, Keam SJ.

Drugs. 2009;69(7):919-42. doi: 10.2165/00003495-200969070-00008. Review.

PMID:
19441874
[PubMed - indexed for MEDLINE]
11.

[Anesthetic management for electroconvulsive therapy using rocuronium bromide and sugammadex sodium in a patient with suspected malignant syndrome].

Maeda T, Enomoto T, Kamiyama Y, Inada E.

Masui. 2011 Dec;60(12):1384-6. Japanese.

PMID:
22256579
[PubMed - indexed for MEDLINE]
12.

Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.

de Boer HD, Driessen JJ, Marcus MA, Kerkkamp H, Heeringa M, Klimek M.

Anesthesiology. 2007 Aug;107(2):239-44.

PMID:
17667567
[PubMed - indexed for MEDLINE]
Free Article
13.

The use of rocuronium and sugammadex in a patient with a history of suxamethonium allergy.

Messer B, Wilkes J.

Anaesthesia. 2011 Sep;66(9):844. doi: 10.1111/j.1365-2044.2011.06806.x. No abstract available.

PMID:
21831084
[PubMed - indexed for MEDLINE]
14.

Rocuronium-sugammadex use in electroconvulsive therapy of patients with pseudocholinesterase enzyme deficiency.

Yuksel E, Sergin D, Tanatti B, Alper I.

J Clin Anesth. 2013 Dec;25(8):680-1. doi: 10.1016/j.jclinane.2013.07.008. Epub 2013 Oct 3. No abstract available.

PMID:
24095888
[PubMed - indexed for MEDLINE]
15.

Recovery time after sugammadex reversal of rocuronium-induced muscle relaxation for electroconvulsive therapy is independent of cardiac output in both young and elderly patients.

Kadoi Y, Nishida A, Saito S.

J ECT. 2013 Mar;29(1):33-6. doi: 10.1097/YCT.0b013e31826cf348.

PMID:
23052151
[PubMed - indexed for MEDLINE]
16.

Effective reversal of moderate rocuronium- or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent.

Suy K, Morias K, Cammu G, Hans P, van Duijnhoven WG, Heeringa M, Demeyer I.

Anesthesiology. 2007 Feb;106(2):283-8.

PMID:
17264722
[PubMed - indexed for MEDLINE]
Free Article
17.

Reversal of rocuronium-induced (1.2 mg kg-1) profound neuromuscular block by accidental high dose of sugammadex (40 mg kg-1).

Molina AL, de Boer HD, Klimek M, Heeringa M, Klein J.

Br J Anaesth. 2007 May;98(5):624-7. Epub 2007 Mar 8.

PMID:
17347184
[PubMed - indexed for MEDLINE]
Free Article
18.

Neuromuscular transmission: new concepts and agents.

de Boer HD.

J Crit Care. 2009 Mar;24(1):36-42. doi: 10.1016/j.jcrc.2008.08.004. Epub 2009 Jan 17. Review.

PMID:
19272537
[PubMed - indexed for MEDLINE]
19.

Use of rocuronium-sugammadex, an alternative to succinylcholine, as a muscle relaxant during electroconvulsive therapy.

Hoshi H, Kadoi Y, Kamiyama J, Nishida A, Saito H, Taguchi M, Saito S.

J Anesth. 2011 Apr;25(2):286-90. doi: 10.1007/s00540-011-1095-6. Epub 2011 Feb 4.

PMID:
21293886
[PubMed - indexed for MEDLINE]
20.

An update on sugammadex sodium.

Welliver M, Cheek D.

AANA J. 2009 Jun;77(3):219-28. Review.

PMID:
19645172
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk